Allo HSCT for High Risk Hemoglobinopathies
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
- Status
- RECRUITING
- Phase
- PHASE1
CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
- Status
- RECRUITING
- Phase
- PHASE1
Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
US Zamto-cel Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE1
Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
- Status
- RECRUITING
- Phase
- PHASE2